Noda S, Kawata S, Miyoshi S, Minami Y, Tarui S
Second Department of Internal Medicine, Osaka University Medical School, Japan.
Gastroenterol Jpn. 1989 Apr;24(2):159-63. doi: 10.1007/BF02774191.
The antipyrine metabolizing capacity was studied in 12 patients with cirrhosis of the liver and 12 with cirrhosis and hepatocellular carcinoma (HCC). Antipyrine clearance (Cl) and liver volume (LV) were measured and the antipyrine clearance per unit liver volume (Cl/LV) was calculated. The patients with HCC showed a significantly lower Cl value than those without HCC but there was no significant difference in Cl/LV between the two groups. This suggested that the lower Cl values in the HCC patients resulted from a decrease in residual liver mass. Cl/LV showed positive correlation with % parenchymal cell mass as an indicator of residual parenchymal cell mass per unit volume of liver. This result showed a correlation of Cl/LV with histological change of the liver in cirrhotics.
对12例肝硬化患者和12例肝硬化合并肝细胞癌(HCC)患者的安替比林代谢能力进行了研究。测量了安替比林清除率(Cl)和肝脏体积(LV),并计算了单位肝脏体积的安替比林清除率(Cl/LV)。HCC患者的Cl值显著低于无HCC患者,但两组之间的Cl/LV无显著差异。这表明HCC患者较低的Cl值是由于残余肝实质减少所致。Cl/LV与作为单位肝脏体积残余实质细胞质量指标的实质细胞质量百分比呈正相关。该结果显示了Cl/LV与肝硬化患者肝脏组织学变化之间的相关性。